May 06, 2025
Mylan Pharmaceuticals Inc. can enter the market in 2032 with a generic anti-nausea drug to compete with Heron Therapeutics Inc. products after the companies settled patent infringement litigation in Delaware federal court.
September 18, 2023
Heron Therapeutics has hit competitor Mylan Pharmaceuticals with a lawsuit in Delaware federal court claiming Mylan's plans for a generic nausea treatment infringe its patents.